Littler R M, Polton G A, Brearley M J
Davies Veterinary Specialists, Manor Farm Business Park, Higham Gobion, Herts, UK.
J Small Anim Pract. 2006 Jul;47(7):392-5. doi: 10.1111/j.1748-5827.2006.00078.x.
The use of insulin-like growth factor 1 assays in the diagnosis and subsequent monitoring after radiotherapy of an acromegalic cat with a secretory pituitary adenoma and secondary insulin-resistant diabetes mellitus is described. Diabetes resolved, and exogenous insulin was no longer required for the maintenance of normoglycaemia 10 months after completion of a course of hypofractionated radiotherapy. However, insulin-like growth factor 1 remained elevated, and the cat's size and appetite continued to increase. It is suggested that radiotherapy may decrease growth hormone concentration to a level such that diabetogenic effects are no longer evident but not to a level required to decrease insulin-like growth factor 1 secretion.
本文描述了胰岛素样生长因子-1检测在一只患有分泌性垂体腺瘤及继发性胰岛素抵抗性糖尿病的肢端肥大症猫放疗诊断及后续监测中的应用。在完成短程分割放疗疗程10个月后,糖尿病得到缓解,维持正常血糖水平不再需要外源性胰岛素。然而,胰岛素样生长因子-1仍处于升高状态,且猫的体型和食欲持续增加。这表明放疗可能会将生长激素浓度降低至糖尿病致病效应不再明显的水平,但不足以降低胰岛素样生长因子-1的分泌水平。